PENBLOCK
Search
← ALL EVENTS
HIGH CONFIDENCENOT IN MAINSTREAM YETFIRST OBSERVED 9 MONTHS AGO

Rep. April McClain Delaney discloses trade(s) in TECH, BJ, IDXX, LH, MORN

April McClain Delaney (MD06) disclosed 15 transactions, traded Jan 12 – Jan 30: 1 purchase and 14 sales.

TradedTickerCompanyActionAmountOwner
Jan 30PTCPTC Inc.Sell$1,001 - $15,000Dependent child
Jan 30WABWestinghouse Air Brake Technologies CorporationSell (partial)$1,001 - $15,000Dependent child
Jan 29TRMBTrimble Inc.Sell (partial)$1,001 - $15,000Dependent child
Jan 28TECHBio-Techne CorpSell (partial)$1,001 - $15,000Dependent child
Jan 28BJBJ's Wholesale Club Holdings, Inc.Sell (partial)$1,001 - $15,000Dependent child
Jan 28LHLabcorp Holdings Inc.Buy$1,001 - $15,000Dependent child
Jan 28TRMBTrimble Inc.Sell (partial)$1,001 - $15,000Dependent child
Jan 23PTCPTC Inc.Sell (partial)$1,001 - $15,000Dependent child
Jan 22SGISomnigroup International Inc.Sell (partial)$1,001 - $15,000Dependent child
Jan 22WABWestinghouse Air Brake Technologies CorporationSell (partial)$1,001 - $15,000Dependent child
Jan 15MORNMorningstar, Inc.Sell (partial)$1,001 - $15,000Dependent child
Jan 14WABWestinghouse Air Brake Technologies CorporationSell (partial)$1,001 - $15,000Dependent child
Jan 13IDXXIDEXX Laboratories, Inc.Sell$1,001 - $15,000Dependent child
Jan 13VIKViking Holdings LtdSell (partial)$1,001 - $15,000Dependent child
Jan 12SGISomnigroup International Inc.Sell (partial)$1,001 - $15,000Dependent child

ORIGINAL FILING ↗ALL FILINGS BY APRIL MCCLAIN DELANEY →CONGRESS TRADES DASHBOARD →

Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.

What This Means

A U.S. representative filed a financial disclosure covering equity transactions across healthcare, consumer retail, and financial services sectors. Congressional stock trading disclosures are public record and tracked by markets observers for potential conflicts of interest or insight into lawmakers' asset allocation decisions. The trades themselves carry no inherent market signal unless part of a broader pattern or tied to legislative activity affecting those companies.

Sources (1)

Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.

FILING1 report

How This Could Play Out

First assessed Sep 27

Resolved

UNLIKELY

A disclosure filing itself requires no resolution—it is a completed administrative act. However, if subsequent reporting or congressional action were to clarify the strategic intent behind the portfolio rebalancing (e.g., a public statement on sector outlook), it might reduce speculation about insider positioning, though the effect on individual securities would likely be negligible.

Status quo

LIKELY

Routine congressional financial disclosures typically attract minimal market attention unless paired with material news about the representative's committee assignments or legislative priorities; absent such context, these trades would be filed and archived without moving prices in the affected securities.

Worsens

POSSIBLE

If media or watchdog organizations were to highlight a pattern of trades that coincides with legislative action on healthcare, technology, or supply-chain regulation affecting these sectors, it could trigger scrutiny around potential conflicts of interest, which might create reputational pressure on the representative or her committee work rather than direct price movement in the underlying stocks.

SPONSORED

More on Congressional Stock Trading

ALL CONGRESSIONAL STOCK TRADING COVERAGE →

Get the market digest by email

One email each morning: yesterday's key story and what it means for markets. Free.